Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge
1Department of Orthopaedics, Huaihe Hospital of Henan University, PR China.
Abstract:
Circular RNAs (circRNAs) is a novel type of non-coding RNAs generated from back splicing, which has been verified to mediate multiple tumorigenesis. However, the role of circRNA in osteosarcoma is still unclear. In the present study, we preliminarily screened the circRNAs expression profiles in osteosarcoma and investigated the potential regulation mechanism. The circRNAs expression profiles in osteosarcoma were screened using circRNA microarray analysis, and results showed that there were 1152 circRNAs up-regulated and 915 circRNAs down-regulated in tumor tissue compared to adjacent tissue. Hsa_circ_0001564, located at 5q35.3 and its associated-gene symbol is CANX, was one of the significantly overexpressed circRNAs in osteosarcoma tissue, as well as in osteosarcoma cell lines. In functional experiments, hsa_circ_001564 knockdown significantly suppressed the proliferation activity, induced cell cycle arrest in G0/G1 phase, and promoted apoptosis in HOS and MG-63 cells. Subsequently, we explored the probable mechanism of hsa_circ_001564, and fortunately, bioinformatics analysis revealed that miR-29c-3p contained the complementary binding region with hsa_circ_0001564, which was confirmed by dual-luciferase reporter assay. Moreover, rescue experiments illustrated that miR-29c-3p could reverse the oncogenesis effect of hsa_circ_001564. Our study discovers that hsa_circ_0001564 acts as miR-29c-3p sponge to mediate the tumorigenicity, which could act as a potential biomarker for the osteosarcoma and provide a novel insight for competing endogenous RNAs (ceRNAs) mechanism in osteosarcoma.
Insights
Circular RNAs (circRNAs) are involved in cancer. This study found that hsa_circ_0001564 promotes osteosarcoma by sponging miR-29c-3p, suggesting it as a potential biomarker.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Circular RNAs (circRNAs) are novel non-coding RNAs implicated in tumorigenesis.
- The specific role of circRNAs in osteosarcoma remains largely uncharacterized.
- Understanding circRNA functions is crucial for developing new cancer therapies.
Purpose of the Study:
- To investigate the expression profile of circRNAs in osteosarcoma.
- To identify specific circRNAs involved in osteosarcoma development and progression.
- To elucidate the underlying molecular mechanisms of identified circRNAs in osteosarcoma.
Main Methods:
- CircRNA microarray analysis to screen differential expression in osteosarcoma tissues and cell lines.
- Functional assays (knockdown, cell cycle, apoptosis) to assess the role of hsa_circ_0001564.
- Bioinformatics analysis and dual-luciferase reporter assays to confirm the interaction between hsa_circ_0001564 and miR-29c-3p.
Main Results:
- 1152 circRNAs were upregulated and 915 downregulated in osteosarcoma tissues.
- Hsa_circ_0001564 was significantly overexpressed in osteosarcoma tissues and cell lines.
- Hsa_circ_0001564 knockdown inhibited proliferation, induced G0/G1 arrest, and promoted apoptosis.
- Hsa_circ_0001564 acts as a sponge for miR-29c-3p, reversing its oncogenic effects.
Conclusions:
- Hsa_circ_0001564 plays a crucial role in promoting osteosarcoma tumorigenesis.
- Hsa_circ_0001564 functions as a competing endogenous RNA (ceRNA) by sponging miR-29c-3p.
- Hsa_circ_0001564 represents a potential diagnostic biomarker and therapeutic target for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
